Home » Stocks » International Isotopes

International Isotopes Inc. (INIS)

Stock Price: $0.0600 USD -0.0048 (-7.41%)
Updated Aug 12, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 25.43M
Revenue (ttm) 8.76M
Net Income (ttm) -1.89M
Shares Out 423.71M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $0.0600
Previous Close $0.0648
Change ($) -0.0048
Change (%) -7.41%
Day's Open 0.0645
Day's Range 0.0615 - 0.0645
Day's Volume 19,700
52-Week Range 0.0421 - 0.0720

More Stats

Market Cap 25.43M
Enterprise Value 30.15M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 423.71M
Float 223.45M
EPS (basic) n/a
EPS (diluted) -0.01
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.30%
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.00
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 335.03
PS Ratio 2.90
PB Ratio n/a
Revenue 8.76M
Operating Income -910,165
Net Income -1.89M
Free Cash Flow 75,896
Net Cash -4.72M
Net Cash / Share -0.01
Gross Margin 53.24%
Operating Margin -10.39%
Profit Margin -21.60%
FCF Margin 0.87%
ROA -3.64%
ROE -651.61%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$0.12*
Low
0.12
Current: $0.0600
High
0.12
Target: 0.12
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue8.9610.377.426.557.067.546.857.629.466.11
Revenue Growth-13.63%39.73%13.25%-7.22%-6.3%10.04%-10.14%-19.45%54.93%-
Gross Profit4.674.693.242.842.702.982.542.653.422.49
Operating Income-0.56-0.29-2.07-1.50-1.44-0.79-2.10-2.18-3.37-6.33
Net Income-1.52-0.84-3.76-1.88-1.82-1.55-2.46-2.24-5.95-6.80
Shares Outstanding418411406403398369365360335300
Earnings Per Share---0.01----0.01-0.01-0.02-0.02
Operating Cash Flow-0.050.10-0.47-0.320.340.34-1.39-2.730.07-4.56
Capital Expenditures-0.21-0.09-0.11-0.09-0.09-0.12-0.56-1.84-3.51-0.01
Free Cash Flow-0.260.01-0.58-0.410.250.22-1.96-4.57-3.44-4.57
Cash & Equivalents0.580.830.800.310.400.560.460.552.104.24
Total Debt3.474.443.206.434.184.344.402.810.533.75
Net Cash / Debt-2.90-3.61-2.41-6.11-3.78-3.78-3.95-2.271.570.49
Assets15.2612.9912.0111.3811.2410.9512.0112.0411.9311.23
Liabilities15.3712.8411.669.627.666.977.165.984.506.39
Book Value-2.19-1.60-1.231.713.523.904.785.977.304.65
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name International Isotopes Inc.
Country United States
Employees 35
CEO Steve T. Laflin

Stock Information

Ticker Symbol INIS
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: INIS
IPO Date August 14, 1997

Description

International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services. The company operates in five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy or various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals for medical, industrial, and research applications. It provides sodium iodide, cobalt-57, cesium-137, germanium?68, sodium-22, and barium-133 isotopes. The Fluorine Products segment offers products that are used to support the production and sale of gases produced using its fluorine extraction process. The Radiological Services segment decommissions disused irradiation units, performs sealed source exchanges in irradiation and therapy units, and processes gemstones, as well as offers transportation services. The company sells its products directly to end users and distributors. International Isotopes, Inc. was founded in 1995 and is headquartered in Idaho Falls, Idaho.